All articles by
Bayer recalls cancer drug Vitrakvi’s one lot due to contamination
The firm believes that the individuals using the Vitrakvi could consume the fungus and develop invasive blood fungal infections or potentially fatal pneumonia as they already have weakened immune systems
Major collaborative childhood cancer research programme launched with £5.5m funding from Children with Cancer UK and Cancer Research UK
SMPaeds2 will investigate blood cancers and solid tumours in children and young people, including in the brain, muscle and bone, which can be more difficult to access, diagnose and treat
Teva Announces Approval of a Generic Version of Forteo in US
The approval and subsequent launch will enhance access to a critical treatment option for patients while serving to demonstrate Teva’s strategic goal of sustaining a generic powerhouse
Health Canada approves Jemperli combo to treat dMMR/MSI-H endometrial cancer
The approval was supported by interim analysis findings from Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO Phase 3 study in which the combination met the primary endpoint of overall survival
Daiichi Sankyo Reaches Agreement with MHLW to Supply Omicron XBB.1.5-adapted COVID-19 Vaccine (DS-5670) in Japan
DS-5670 is an mRNA vaccine against COVID-19 designed to produce antibodies against the receptor binding domain (RBD) of the spike protein of the novel coronavirus, utilizing a novel nucleic acid drug delivery system discovered by Daiichi Sankyo
LENZ Therapeutics to merge with Graphite Bio in all-stock deal
The primary focus of the combined entity’s lead programmes will be on addressing presbyopia, the age-related decline in near vision affecting individuals over the age of 45
Cystic fibrosis drugs Kaftrio and Kalydeco licensed for patients aged two to five years old
For the first time, 2- to 5-year-old patients with a certain type of cystic fibrosis could access cystic fibrosis drugs Kaftrio and Kalydeco
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
Execution of binding subsequent investment agreement regarding contemplated additional equity investment of $140M by AstraZeneca, previously announced on November 1, 2023
Oracle enhances healthcare inventory management with new mobile capabilities
The new capabilities are expected to assist healthcare firms in bringing down inventory errors and increasing the effectiveness of restocking
Axtria Introduces AI-Enabled Solution for Emerging Biotech and Pharmaceutical Companies
Ingenious insights democratised to support the unique needs of small and emerging companies, including those that focus on specialty drugs